Literature DB >> 24785793

You never know when your last day will come and your trip will be over--existential expressions from a melanoma diagnosis.

Senada Hajdarevic1, Birgit H Rasmussen2, Åsa Hörnsten3.   

Abstract

AIM: The aim of this study was to further explore expressions of existential experiences by patients diagnosed with malignant melanoma (MM).
METHOD: Semi-structured interviews were performed consecutively after diagnosis among 30 patients with MM. The methodological approach was inspired by Gadamer's hermeneutic philosophy.
RESULTS: The analysis of expressions of existential experiences after having been diagnosed with malignant melanoma revealed that it is an existential process that people go through, beginning with feelings of suddenly becoming groundless at the time of the diagnosis, including being empty and in a vacuum, being in chaos and uncertainty and being confronted with one's own death. Next theme searching for solid ground included striving to understand what lies ahead, striving to find a balance in life - fighting, hoping, going on living and striving to prioritize family. The last theme creating islands of solid ground when living with cancer included understanding what is meaningful in life, living in the moment - seizing the day and keeping watch on the body.
CONCLUSION: On being diagnosed with malignant melanoma, people go through a process where many questions emerge, including an existential turmoil, which health professionals should be aware of to provide these patients with sufficient support.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer experience; Existential expression; Existential suffering; Groundlessness; Life disruption; Malignant melanoma; Nursing; Qualitative method

Mesh:

Year:  2014        PMID: 24785793     DOI: 10.1016/j.ejon.2014.03.015

Source DB:  PubMed          Journal:  Eur J Oncol Nurs        ISSN: 1462-3889            Impact factor:   2.398


  3 in total

1.  Certainty within uncertainty: a qualitative study of the experience of metastatic melanoma patients undergoing pembrolizumab immunotherapy.

Authors:  David Levy; Haryana M Dhillon; Anna Lomax; Michael Marthick; Catriona McNeil; Steven Kao; Judith Lacey
Journal:  Support Care Cancer       Date:  2018-09-04       Impact factor: 3.603

2.  Demonstrating the importance of cultural considerations at end of life utilizing the perspective of Indian patients with cancer.

Authors:  Mahati Chittem; Jaklin Eliott; Ian Olver
Journal:  Support Care Cancer       Date:  2021-11-17       Impact factor: 3.603

3.  Health Behaviour Changes of Cutaneous Melanoma Survivors in Slovenia - A Qualitative Study.

Authors:  Mirjam Rogl Butina; Igor Švab; Barbara Perić; Igor Bartenjev
Journal:  Zdr Varst       Date:  2019-03-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.